Kailera Therapeutics
Advanced injectable obesity treatments
- B2B
About Kailera Therapeutics
Development of clinical-stage injectable and oral therapies targeting obesity, including dual agonist drugs with positive trial results in China.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Founded
- 2024
- Revenue
- $15.7M – $124MTamtam estimate
- linkedin.com/company/kaileratx
Kailera Therapeutics at a glance
Kailera Therapeutics is a B2B company in the Biotechnology Research industry.
Kailera Therapeutics was founded in 2024.
Kailera Therapeutics has 51–250 employees.
Kailera Therapeutics's revenue is $15.7M – $124M (Tamtam estimate).
Frequently asked questions about Kailera Therapeutics
What is Kailera Therapeutics's revenue?
Tamtam estimates Kailera Therapeutics's annual revenue at $15.7M – $124M.
How many employees does Kailera Therapeutics have?
Kailera Therapeutics has 51–250 employees.
Selling to companies like Kailera Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies